Pacira BioSciences (PCRX) Asset Utilization Ratio (2011 - 2026)
Pacira BioSciences (PCRX) posted Asset Utilization Ratio of 0.61 for Q2 2026, up 2.4% on a QoQ basis from 0.59 in Q1 2026, and up 34.65% year-over-year from 0.45 in Q2 2025.
Analysis
Pacira BioSciences (PCRX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Pacira BioSciences has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.61 in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio rose 34.65% year-over-year to 0.61 in Q2 2026; TTM through Jun 2026 was 0.61, a 34.65% increase from a year earlier, with the FY2025 full-year figure at 0.52, up 15.01% from the prior year.
- Asset Utilization Ratio was 0.61 for Q2 2026 at Pacira BioSciences, up from 0.59 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.61 in Q2 2026, with the low at 0.29 in Q1 2022.
- Average Asset Utilization Ratio over 5 years is 0.45, with a median of 0.44 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio decreased 15.36% in 2022, then surged 42.69% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.39 in 2022, then rose by 11.21% to 0.43 in 2023, then grew by 4.99% to 0.46 in 2024, then advanced by 24.36% to 0.57 in 2025, then gained by 7.33% to 0.61 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.61 (Q2 2026), 0.59 (Q1 2026), and 0.57 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | 0.57 |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 0.36 |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 0.77 |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 0.45 |
| 10 | Pacira BioSciences | 1.01 Bn | 756.04 Mn | 148.24 Mn | 0.61 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.61 |
| Mar 31, 2026 | 0.59 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.45 |
| Mar 31, 2025 | 0.45 |
| Dec 31, 2024 | 0.46 |
| Sep 30, 2024 | 0.44 |
| Jun 30, 2024 | 0.43 |
| Mar 31, 2024 | 0.43 |
| Dec 31, 2023 | 0.43 |
| Sep 30, 2023 | 0.43 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | 0.42 |
| Dec 31, 2022 | 0.39 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.38 |